| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |